ACCURAY INC
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
About Accuray
Surgical & Medical Instruments & Apparatus, SIC 3841
Accuray Incorporated develops, manufactures, sells, and supports radiation therapy solutions, including treatment delivery, planning, imaging, and data management systems. Its core offerings feature the CyberKnife robotic platform and helical systems such as Accuray Stellar, Radixact, Accuray Helix, and Tomo C. The company also provides integrated software solutions, such as the Accuray Precision Treatment Planning System and iDMS Data Management System, alongside professional services like customer support, installation, and training. Accuray serves clinicians, hospitals, cancer centers, and healthcare providers, with its equipment utilized by radiation oncologists and neurosurgeons to treat cancerous and benign tumors and selected functional disorders.
Accuray operates regional offices outside the United States in Morges, Switzerland; Hong Kong, China; Shanghai, China; and Tokyo, Japan. The company maintains direct sales personnel in most of Western Europe, Canada, Japan, India, and Korea, while utilizing distributors across selected markets in Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Accuray maintains its principal United States office in Madison, Wisconsin.
Summary of the business section of Accuray's latest annual report, written by StockData.
Company profile
Company
- Legal name
- ACCURAY INC
- Founded
- 1990
- Headquarters
- Madison, WI
- Address
- 1240 Deming Way 53717
- Phone
- (608) 824-2800
- Employees
- 809, Jun 30, 2026
- Industry
- Surgical & Medical Instruments & Apparatus
- Incorporated in
- Delaware
- Fiscal year ends
- June 30
- Auditor
- GRANT THORNTON LLP, San Jose, California
Stock & identifiers
- Ticker
- ARAY
- Exchange
- Nasdaq
- IPO date
- Feb 8, 2007
- Shares outstanding
- 119M, Aug 21, 2026
- Public float
- $86.94M, Dec 31, 2025
- Filer category
- Accelerated filer<br>Smaller reporting company
- SEC CIK
- 1138723
- CUSIP
- 004397105
- ISIN
- US0043971052
- LEI
- 549300G28LY4TZKZJG51
- EIN
- 20-8370041
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Neve Stephen R. La | CEO, Director | 20,000 |
| Paul Michael Miele | SVP, Chief Commercial Officer | – |
| Sandeep Chalke | SVP, Chief Commercial Officer | 419,806 |
| Leonel Peralta | SVP, Chief Operations Officer | 54,754 |
| Ali Pervaiz | SVP Chief Financial Officer | 352,863 |
| Michael John Murphy | VP, Corporate Controller | 25,499 |
| Suzanne C. Winter | President and CEO | 1,200,047 |
| Michael Hoge | Senior VP Global Operations | 357,431 |
| Jesse Chew | Chief Legal Officer | 326,824 |
| Steven F. Mayer | Director | 1,545,620 |
| Byron C. Scott | Director | 162,727 |
| Beverly A. Huss | Director | 243,965 |
| James M. Hindman | Director | 294,804 |
| Chan Galbato | Director | 50,000 |
| Grand Anne Bryce Le | Director | 259,499 |
| Mika Nishimura | Director | 212,659 |
| Joseph E. Whitters | Director | 667,656 |
| Robert Kill | Director | 262,809 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Sandeep Chalke | $1.20M | $602.27K | $1.23M | $70 | – |
| FY2025 Suzanne Winter | $3.04M | $1.20M | $1.23M | $70 | – |
| FY2024 Suzanne Winter | $3.52M | -$125.70K | $1.17M | $93 | – |
| FY2023 Suzanne Winter | $2.64M | $4.50M | $1.14M | $197 | – |
| FY2022 Suzanne Winter | $3.98M | $1.62M | $1.15M | $48 | $166 |
| FY2021 Suzanne Winter | $4.11M | $4.08M | $1.35M | $110 | $160 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of June 30, 2026, we had 809 employees, including 392 employees employed outside of the United States.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Aug 6, 2026 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Feb 9, 2026 | Late filing | Notification of late filing |
| Feb 6, 2026 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Sep 16, 2024 | Late filing | Notification of late filing |
| Sep 13, 2011 | Late filing | Notification of late filing |
| Jun 13, 2011 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Apr 7, 2011 | Merger | Registration of securities for a merger or exchange offer (S-4) |
| Nov 20, 2008 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Nov 7, 2008 | Late filing | Notification of late filing |
| Feb 8, 2007 | IPO | Initial public offering priced (424B4 prospectus) |
| Feb 7, 2007 | Listing | Registration of securities on an exchange (Form 8-A) |